Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 31OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Breast Neoplasms 107Neoplasms 70Colorectal Neoplasms 51Uterine Cervical Neoplasms 41Prostatic Neoplasms 32Stomach Neoplasms 31Motor Activity 26Carcinoma, Hepatocellular 24Lung Neoplasms 22Rectal Neoplasms 21Colonic Neoplasms 19Head and Neck Neoplasms 18Pancreatic Neoplasms 17Brain Neoplasms 15Pain 14Polycystic Ovary Syndrome 13Recurrence 12Pain, Postoperative 11Lymphoma 11Esophageal Neoplasms 11Anxiety Disorders 11Ovarian Neoplasms 10Glioma 10Endometrial Neoplasms 10Thyroid Neoplasms 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Pilonidal Sinus 9Carcinoma, Non-Small-Cell Lung 9Papillomavirus Infections 8Hematologic Neoplasms 8

Interventions

Radiotherapy, Intensity-Modulated 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × OTHER_GOV × Gynecologic Cancer × Clear all
NCT03899376 2023-11-14

ATGCRT

National Institute of Cancerología

Phase NA Unknown
80 enrolled
Gynecologic

Gynecologic Cancer

NCT03258307 2019-08-06

Comparison of Perilipin, Leptin, Adipolipin, Adiponectin, Resistin, Visfatin, Estrone Levels Pre-post Omentectomy

Istanbul Training and Research Hospital

Phase NA Completed
25 enrolled
Gynecologic

Gynecologic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡